Growing Alcohol Consumption and Alcohol-Impaired Accidents Fuel to Asia Pacific Breath Analyzer Market
According to the World Data report published in 2022, the average consumption of alcohol across the world is 6.182 liters per person. The World Health Organization (WHO) reveals that excessive alcohol consumption results in 3 million deaths every year (representing 5.3% of the overall deaths worldwide), causing harm to the well-being and health of people. Additionally, 5.1% of the global burden of disease and injury caused to an individual due to alcohol drunken driving causes social and economic losses to individuals and society. Excessive alcohol consumption results in road traffic crashes and accidents.In Australia, drunk driving accounts for about 30% of fatal collisions, with more than one in four drivers and passengers who die had blood alcohol content (BAC) levels above the permitted limit. According to police collision data, around one out of every three fatal crashes is caused by speeding. 163 individuals lost their lives in heavy vehicle accidents on the roads in 2021. This represents 15.4% of all traffic deaths. Also, according to data from the Korlantas Polri Directorate of Law Enforcement, there were 121,641 road accidents in total year 2019 in Indonesia. 0.73% of such incidents were the result of intoxicated driving. Therefore, the rising number of deaths due to accidents caused by drunken driving accelerates demand for breath analyzers.
Asia Pacific Breath Analyzer Market Overview
Asia Pacific region is segmented as China, Japan, India, Australia, South Korea, and Rest of Asia Pacific. Asia Pacific region is dominated by growing accidents due to alcohol driven population and rising government support resulting in high adoption of breath analyzer devices for the forecast period 2020-2030. The breath analyzer market in China is expected to grow during 2020-2030 owing to increasing consumption of alcohol among the Chinese population, rising prevalence of alcohol-impaired driving, and growing awareness about the use of breath analyzers for disease diagnosis. Alcohol consumption is a leading risk factor for poor health and is responsible for over three million deaths worldwide annually. Accidents due to alcohol-impaired driving and rising alcohol-associated disorders are major health concerns for the Chinese population. According to an article published by Frontiers in Psychiatry in November 2020, a retrospective online survey was conducted on a sample of 2,229 participants to assess the drinking behaviors of the participants before and during the COVID-19 pandemic and their current levels of hazardous drinking. The survey found that while there was a slight reduction in alcohol consumption during the pandemic, hazardous drinking remained common, particularly among male drinkers who consumed more alcohol and engaged in riskier behavior than females both before and during the pandemic.Additionally, to address the persistent problem of drinking and driving in China, effective enforcement of laws and public awareness campaigns are needed. According to the Chinese Center for Disease Control and Prevention, in October 2020, the Traffic Management Bureau of the Ministry of Public Security coordinated with public security traffic departments across the country to conduct comprehensive nighttime inspections. As a result, more than 9,000 cases of drinking and driving were detected and penalized, including over 1,500 cases of drunk driving. Therefore, the demand for breath analyzers for alcohol detection is growing in China due to above mentioned factors. Furthermore, researchers in China are engaged in the development of breath analyzers for the detection of disease among the population. In an article published by PubMed in September 2023, a study was carried out to contrast the diagnostic value of the breath tests such as lactulose breath test (LBT) and glucose breath test (GBT) with jejunal aspiration cultures in the diagnosis of small intestinal bacterial overgrowth (SIBO). Therefore, the factors mentioned above drive the breath analyzer market growth in China.
Asia Pacific Breath Analyzer Market Segmentation
The Asia Pacific breath analyzer market is segmented into technology, application, end user, and country.Based on technology, the Asia Pacific breath analyzer market is segmented into fuel cell technology, infrared spectroscopy, semiconductor sensor, and others. The fuel cell technology held the largest share of the Asia Pacific breath analyzer market in 2022.
Based on application, the Asia Pacific breath analyzer market is segmented into alcohol detection, medical applications, and drug abuse detection. The medical applications segment held the largest share of the Asia Pacific breath analyzer market in 2022.
Based on end user, the Asia Pacific breath analyzer market is segmented into hospitals and diagnostic centers, law enforcement agencies, and others. The hospitals and diagnostic centers segment held the largest share of the Asia Pacific breath analyzer market in 2022.
Based on country, the Asia Pacific breath analyzer market is segmented into China, Japan, India, South Korea, Australia, and the Rest Asia Pacific. China dominated the Asia Pacific breath analyzer market in 2022.
Thermo Fisher Scientific Inc, Alcolizer Pty Ltd, Dragerwerk AG & Co KGaA, Abbott Laboratories, Honeywell International Inc, KHN Solutions LLC, Bedfont Scientific Ltd, and Intoximeters Inc are some of the leading companies operating in the Asia Pacific breath analyzer market.
Table of Contents
Companies Mentioned
- Thermo Fisher Scientific Inc
- Alcolizer Pty Ltd
- Dragerwerk AG & Co KGaA
- Abbott Laboratories
- Honeywell International Inc
- KHN Solutions LLC
- Bedfont Scientific Ltd
- Intoximeters Inc